Clinical observation of the effect of Xuesaitong soft capsule on post-hepatitis fibrosis.
OBJECTIVE
To study the effect of Xuesaitong soft capsule (XST) on liver fibrosis criteria in patients with post-hepatitis fibrosis.


METHODS
Sixty-four patients with such fibrosis were randomly divided into the treated group and control group. They were treated with XST and Dahuang Zhechong pill (NFDA1) for 3 months respectively. Their liver fibrosis criteria were examined before and after treatment.


RESULTS
The levels of serum procollagen III, hyaluronic acid, collagen IV, laminin in the two groups were significantly lower (P < 0.01) than those before treatment. The differences between the two groups were insignificant (P > 0.05).


CONCLUSIONS
XST could recover liver dysfunction and had anti-liver fibrosis function.
The First Hospital Affiliated to Medical College of Zhejiang University, Hangzhou, China. deyq@tom.com
Yin-quan
YQ
Deng
Xiao-fen
XF
Fan
You-di
YD
Li
D000328:Adult; D002214:Capsules; D004365:Drugs, Chinese Herbal / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D019694:Hepatitis B, Chronic / Q000150:complications*; D006801:Humans; D008099:Liver / Q000503:physiopathology; D008103:Liver Cirrhosis / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology / Q000821:virology*; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
D002214:Capsules; D004365:Drugs, Chinese Herbal